Jan 8 (Reuters) - Integra Lifesciences Holdings Corp :
* - ‍ORGANIC REVENUE GROWTH IN Q4 IS EXPECTED TO BE ABOUT 5.5%, ABOVE COMPANY‘S IMPLIED GUIDANCE OF ABOUT 4%​
* - ‍IS STILL EVALUATING IMPACT OF TAX CUTS AND JOBS ACT OF 2017 ON ITS GAAP FINANCIAL RESULTS​
* INTEGRA LIFESCIENCES ANNOUNCES PRELIMINARY FOURTH QUARTER 2017 FINANCIAL RESULTS
* SEES Q4 2017 REVENUE ABOUT $365 MILLION * Q4 EARNINGS PER SHARE VIEW $0.55, REVENUE VIEW $351.0 MILLION -- THOMSON REUTERS I/B/E/S
* INTEGRA LIFESCIENCES-Q4 2017 ADJUSTED EPS, EXCLUDING IMPACT FROM TAX CUTS,JOBS ACT OF 2017,TO EXCEED HIGH-END OF PREVIOUS GUIDANCE RANGE OF $0.53 TO $0.57 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)
 